Company: ZVRA
Filing Date: 2025-04-16
Form Type: PRRN14A
Source: 0000897069-25-000815
Chunk: 27

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-16
Form: PRRN14A
Chunk 27
---
 the ability to approve the reimbursement, if each determined, in exercising their fiduciary duty, that this was in the best interests of the Company and its shareholders. None of these persons has any kind of arrangement or agreement to vote in favor of reimbursement, nor with the Proponent seek any such arrangement or agreement from them. Nominee Arthur C. Regan has retained Regan & Associates, Inc., a proxy solicitation firm, to solicit proxies for the Proponent’s Nominees at a fee not to exceed $40,000 plus certain expenses if the solicitation effort is successful. Mr. Regan alone is responsible for this retainer and any expenses associated with the same. ADDITIONAL PARTICIPANT INFORMATION The Participants in the solicitation are Mr. Daniel J. Mangless as the Proponent, and Mr. Travis C. Mickle, PhD, and Mr. Arthur C. Regan as the Nominees. The name and address of the Proponent, as it appears on the Company’s books, is Daniel J. Mangless, 2146 Swanstone Circle, De Pere, Wisconsin 54115. The principal occupation or employment of Mr. Mangless is President of Ivan Gandrud Chevrolet, Inc. The principal business address of Mr. Mangless is 919 Auto Plaza Dr., Green Bay, WI 54302. The business address of each of the Nominees is as set forth elsewhere in this Proxy Statement. As of the date hereof, the Proponent beneficially owns an aggregate of 100 shares of Common Stock in record name and 1,521,095 shares of Common Stock in street name, representing approximately 2.8% of the shares of Common Stock, as reported to be outstanding by the Company as of March 7, 2025. For information regarding purchases and sales of securities of the Company by the Participants, please see Appendix Aattached hereto. Except as disclosed on Appendix A, no Nominee has any substantial interest, direct or indirect, by security holdings or otherwise, in the matters to be brought before the Annual Meeting pursuant to this Proxy Statement. The Nominees have agreed to be nominated by the Proponent at the Annual Meeting. The Proponent hereby represents that he is a holder of record or beneficial owner of shares of the Company entitled to vote at the Annual Meeting, and intends to be present, in person, virtually or by proxy, at the Annual Meeting to nominate the Nominees for election at the Annual Meeting in accordance with the Bylaws. Other